A procedure for the spectrophotometric quantification of thiosens in a new lyophilized liposomal drug form containing lecithin, cholesterol, and PEG-2000-DSPE at a molar ratio of 1:0.22:0.002 in addition to sucrose solution (cryoprotector) at a lecithin:cryoprotectant mass ratio of 1:2 was developed. The influence of excipients on the analytical results and the observance of the Bouguer–Lambert–Beer law was evaluated.
Similar content being viewed by others
References
I. G. Meerovich, Z. S. Smirnova, N. A. Oborotova, et al., Bull. Exp. Biol. Med., 139, No. 4, 427 – 430 (2005).
L. G. Gatinskaya, N. A. Dmitricheva, E. V. Ignat?eva, et al., Ross. Bioterapevticheskii Zh., 1, 33 – 34 (2006).
Z. S. Smirnova, I. G. Meerovich, E. A. Luk?yanets, et al., Ross. Bioterapevticheskii Zh., 1, 54 – 60 (2004).
V. G. Belikov, Ross. Khim. Zh., 4, 52 – 56 (2002).
Acknowledgments
The work was carried out in the framework of the scientific technical program “Development and Practical Implementation in Health of New Methods and Agents for Prevention, Diagnosis, and Treatment of Oncological, Infectious, and Other Serious Diseases” that was financed by the Moscow Government.
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 46, No. 6, pp. 54 – 56, June, 2012.
Rights and permissions
About this article
Cite this article
Sanarova, E.V., Polozkova, A.P., Meerovich, I.G. et al. Quantitative determination of thiosens in a new liposomal drug form. Pharm Chem J 46, 386–388 (2012). https://doi.org/10.1007/s11094-012-0805-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-012-0805-1